Navigation Links
Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for immunodeficiency disorders
Date:3/24/2014

New Rochelle, NY, March 24, 2014Marina Cavazzana, MD, PhD, Paris Descartes University, France and Adrian J. Thrasher, MD, PhD, University College London Institute of Child Health, UK, have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders. Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, is commemorating its 25th anniversary by bestowing this honor on the leading 12 Pioneers in the field of cell and gene therapy selected by a blue ribbon panel* and publishing a Pioneer Perspective by the award recipients

Dr. Cavazzana has been at the forefront of advances in treating life-threatening inherited diseases of the immune system with gene therapy, using a patient's own modified stem cells. She describes the translation of this work to the clinic and its ongoing advances and novel applications in the article "Hematopoetic Stem Cell Gene Therapy: Progress on the Clinical Front." The article by Dr. Cavazzana is available free on the Human Gene Therapy website at http://online.liebertpub.com/doi/full/10.1089/hum.2014.2504.

A pioneer of gene therapy in the UK, Dr. Thrasher has been at the leading edge of basic science research on the function of therapeutic genes for inherited disorders and the development of viral vectors to deliver them to affected patients. He has collaborated on gene therapy clinical trials targeting immunodeficiency disorders with groups in Europe and the USA.

"Cell therapy and gene therapy are advancing together to improve patient care," says Dr. Cavazzana. "We can expect to be able to rebuild a new immune system not only in primary immunodeficiencies but also in severe acquired clinical conditions (such as those in HIV-1-infected patients)."

"I've seen some very exciting times in the field, from the first evidence that biochemical defects can be corrected in vitro, to some remarkable clinical successes in patients with devastating diseases. I look forward with huge enthusiasm to the exciting developments on the horizon, which are likely to impact on more patients with an even wider range of disorders," says Dr. Thrasher.

"These pioneers contributed to the first real clinical successes of gene therapy through their work in inherited immune deficiency disorders," says James M. Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Joseph Glorioso, Ph.D., receives Pioneer Award
2. OU professor recognized by AAAS for pioneering efforts to advance ecological forecasting
3. Ronald Crystal, M.D., receives Pioneer Award
4. David Allis, pioneer in epigenetics, to receive prestigious Japan Prize
5. Pioneering path to electrical conductivity in tinker toy materials to appear in Science
6. Top 12 Pioneer Awards for seminal work in gene and cell therapy selected by blue ribbon panel
7. Biometrics Pioneer DERMALOG Awarded German Foreign Trade Prize
8. 2 online science video pioneers combine to form new iBiology.org
9. Pioneers in Alzheimers research: Research couple honored for its lifetime achievement
10. Oxfords Gero Miesenböck is awarded The Brain Prize 2013 for his pioneering work on optogenetics
11. Manchester patients take part in pioneering heart attack blood test trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for immunodeficiency disorders
(Date:5/25/2020)... ... 22, 2020 , ... Oxford Nanopore Technologies is in advanced development of a ... causes COVID-19. , The LamPORE assay is designed to be rapid, low ... large numbers of samples. Hardware and reagents sit outside current, squeezed supply chains ...
(Date:5/21/2020)... ... May 20, 2020 , ... Law Enforcement has always been ... all of us. The positions of these men and women put them constantly in ... not following rules precisely. Officers have always had to face very high daily stress. ...
(Date:5/14/2020)... ... May 13, 2020 , ... DuPont Nutrition & Biosciences ... the lactose-free dairy market. This unique product allows for process optimization and cost ... competitive costs across North America. , Among the numerous benefits Bonlacta™ offers, it ...
Breaking Biology News(10 mins):
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Innovation Research (SBIR) program to support the expansion of its digital health platform ... which conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government ...
(Date:4/7/2020)... ... April 06, 2020 , ... Red Nucleus, a leading provider ... announced the release of at-home virtual learning resources for all client partners. , ... safety of our employees as we continue to implement measures to safeguard the ...
(Date:4/1/2020)... ... March 30, 2020 , ... A joint ... Diagnostics (RID), formed earlier this year to bring telehealth to various government agencies, ... for COVID-19. Company officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from ...
(Date:4/1/2020)... ... March 31, 2020 , ... Carterra® Inc., the world leader ... announced today that they will use Carterra’s proprietary LSA™ platform to screen hundreds of ... clinic as early as this summer. , La Jolla Institute for Immunology (LJI) ...
Breaking Biology Technology: